Next Article in Journal
The Role of Hypoxia-Induced Mitogenic Factor in Organ-Specific Inflammation in the Lung and Liver: Key Concepts and Gaps in Knowledge Regarding Molecular Mechanisms of Acute or Immune-Mediated Liver Injury
Next Article in Special Issue
Syndecan-1 (CD138), Carcinomas and EMT
Previous Article in Journal
Evidence of p75 Neurotrophin Receptor Involvement in the Central Nervous System Pathogenesis of Classical Scrapie in Sheep and a Transgenic Mouse Model
Previous Article in Special Issue
AP2M1 Supports TGF-β Signals to Promote Collagen Expression by Inhibiting Caveolin Expression
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 22
Issue 5
10.3390/ijms22052716
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Perlecan in Pericellular Mechanosensory Cell-Matrix Communication, Extracellular Matrix Stabilisation and Mechanoregulation of Load-Bearing Connective Tissues

by
Farshid Guilak
1,2,
Anthony J. Hayes
3 and
James Melrose
4,5,6,*
1
Department of Orthopaedic Surgery, Washington University, St. Louis, MO 63110, USA
2
Shriners Hospitals for Children—St. Louis, St. Louis, MO 63110, USA
3
Bioimaging Research Hub, Cardiff School of Biosciences, Cardiff University, Cardiff, Wales CF10 3AX, UK
4
Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW 2052, Australia
5
Raymond Purves Laboratory, Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia
6
Sydney Medical School, Northern, University of Sydney at Royal North Shore Hospital, St. Leonards, NSW 2065, Australia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(5), 2716; https://doi.org/10.3390/ijms22052716
Submission received: 30 January 2021 / Revised: 4 March 2021 / Accepted: 5 March 2021 / Published: 8 March 2021
(This article belongs to the Special Issue Molecular Connection and Influence of Extracellular Matrix with Cancer)
Browse Figures
Versions Notes

Abstract

:
In this study, we review mechanoregulatory roles for perlecan in load-bearing connective tissues. Perlecan facilitates the co-acervation of tropoelastin and assembly of elastic microfibrils in translamellar cross-bridges which, together with fibrillin and elastin stabilise the extracellular matrix of the intervertebral disc annulus fibrosus. Pericellular perlecan interacts with collagen VI and XI to define and stabilize this matrix compartment which has a strategic position facilitating two-way cell-matrix communication between the cell and its wider extracellular matrix. Cues from the extracellular matrix are fed through this pericellular matrix back to the chondrocyte, allowing it to perceive and respond to subtle microenvironmental changes to regulate tissue homeostasis. Thus perlecan plays a key regulatory role in chondrocyte metabolism, and in chondrocyte differentiation. Perlecan acts as a transport proteoglycan carrying poorly soluble, lipid-modified proteins such as the Wnt or Hedgehog families facilitating the establishment of morphogen gradients that drive tissue morphogenesis. Cell surface perlecan on endothelial cells or osteocytes acts as a flow sensor in blood and the lacunar canalicular fluid providing feedback cues to smooth muscle cells regulating vascular tone and blood pressure, and the regulation of bone metabolism by osteocytes highlighting perlecan’s multifaceted roles in load-bearing connective tissues.

1. Introduction

1.1. Perlecan is a Modular Proteoglycan

Perlecan is a large modular, multifunctional heparan sulphate (HS) proteoglycan (HS-PG) that is abundant in vascularized tissues but also occurs in poorly and non-vascularized connective tissues such as articular cartilage, intervertebral disc (IVD), meniscus, ligament and in tendon as a hybrid form, where at least one of its HS glycosaminoglycan (GAG) chains is replaced by a chondroitin sulphate (CS) chain [1,2] (Figure 1a). Smooth muscle cells (SMCs) synthesize a CS/HS hybrid form of perlecan whereas keratinocytes in epithelial tissues synthesize a form containing CS, HS and keratan sulphate (KS) [3], and endothelial cell perlecan is mono-substituted with HS. Mast cells synthesize perlecan species with smaller molecular weight core proteins [4] apparently arising from alternative splicing and/or protease cleavages in the immunoglobulin-rich domain IV, thus generating N and C terminal perlecan fragments of variable size. Some of these fragments act as functional PGs in their own right [5].

1.2. Perlecan’s Participation in Physiological Processes

Perlecan also has important regulatory roles in many physiological processes. Perlecan on endothelial cells in the lumen of blood vessels acts as a dynamic flow sensor [6] with detected shear forces regulating endothelial membrane polarization, cell proliferation, cytoskeletal organization and gene expression [7]. Furthermore, this is coupled with stimulatory biophysical forces that promote cell differentiation and tissue development [8]. Calcium signalling through transient receptor potential (TRP) channels in endothelial cells drives vasculogenic processes [9]. TRP channels also regulate the contractile properties of SMCs to regulate vasodilation and blood pressure [10]. Perlecan, is a mechanical biosensor in bone, detecting external loading through the identification of solute movement in the lacuno-canalicular space of the bone matrix [11,12,13].

1.3. The Role of Perlecan in Chondrocyte Mechanotransduction

Mechanotransduction—the conversion of a mechanical signal to an intracellular response—is a crucial process in the homeostatic maintenance of connective tissues such as cartilage. Deformation of cartilaginous tissues during normal daily activities exposes the chondrocytes to varying stresses, strains, hydrostatic pressure, interstitial fluid flow, electrokinetic effects and ionic changes that alter the local osmotic pressure [14]. Compression of the cartilage matrix causes water to be exuded from the tissue, while the negatively charged proteoglycans (PGs) are retained and attract positive counter-ions. This phenomenon results in fluctuations in the interstitial osmolarity of the ECM and pericellular matrix (PCM) [15,16] which can influence the physiologic activity of the chondrocyte [17,18]. In the last ten years, several ion channels, pumps or exchangers have been identified in the cell membrane of chondrocytes and shown to have important regulatory roles [19,20,21,22,23,24,25]. For example, the electrogenic Na+ /K+pump regulates Na+, K+ -ATPase and the resting potential of the chondrocyte [21]. Electrochemical gradients of Na+ and K+ are established and maintained by this active ATP-requiring pump [26,27]. The presence of Na+/K+, pump proteins in the chondrocyte cell membrane have been identified using immunological and autoradiographic techniques and multiple α, β, and γ, isoform subunits identified [28,29,30]. Proteomic studies on the chondrocyte ‘‘surface-ome’’, have confirmed the presence of multiple Na+/K+ pump isoforms [19]. As the ionic environment around chondrocytes clearly fluctuates during mechanical loading and relaxation cycles, chondrocytes have been shown to respond to changes in osmolarity with transient changes in intracellular Ca2+ that ultimately regulate the cells’ metabolic function and matrix synthesis [31]. Recent studies suggest that this mechano-osmotic transduction occurs via interactions of the ion channel transient receptor potential vanilloid 4 (TRPV4), a non-selective cation channel that is highly expressed in chondrocytes and interacts with the PCM [32]. The prominent localization of perlecan in the chondrocyte PCM stabilizes this pericellular environment and may regulate the maintenance of Ca2+ or Na+/K+ gradients in healthy chondrocytes, disruption of the PCM in arthritic chondrocytes may contribute to alterations in intracellular signaling and loss of chondrocyte homeostatis [32].
In addition to direct cellular signalling through mechanosensitive ion channels, growing evidence suggests that the ECM and PCM themselves can play important roles in transducing physiologic and pathologic mechanical signals in the cellular environment [33]. For example, fibroblast growth factor-2 (FGF-2), a major perlecan ligand, has been shown to serve as a mechanotransducer in the response of cartilage to trauma. Perlecan and FGF-2 are co-localised within the type VI collagen-rich PCM of articular cartilage. In damaged cartilage, chondrocytes release FGF-2 resulting in the activation of extracellular signal-regulated kinases (ERKs) and the induction of chondrocyte regulatory proteins including TIMP-1 and MMP-1 and 3 [34,35].
Biomechanical measurements conducted on single and groups of chondrocytes show that in cartilage, when a chondrocyte progresses from a single cell to a string of cells to a small and then larger cell cluster there is a progressive measurable decrease in stiffness in the PCM. This relaxation of the PCM makes the enclosed chondrocyte more amenable to influences from external stimuli from the ECM. The PCM also becomes more susceptible to proteolytic attack during the pathogenesis of OA [36]. In contrast to the wider, load-bearing ECM, the PCM contains relatively higher PG levels. Furthermore, small leucine repeat proteoglycan (SLRP) family members, such as biglycan and decorin, attach to the type VI collagen of the chondron [37] forming bridging structures between collagen and aggrecan-and HA networks. Perlecan, discussed in detail below, is also interactive with type VI collagen in the PCM [38] at all stages of joint development [39,40,41,42] contributing to the unique mechanical properties of the chondron [43]. This collagen-PG interconnectivity gives rise to coupled mechanosensory networks that extend out of the PCM into the inter-territorial matrix. These networks allow responsive remote sensing of the extracellular environment whereby environmental cues (e.g., perturbations in ECM) are fed back to the chondrocyte that responds appropriately to maintain cartilage homeostasis [44,45]. Collagen-PG networks contribute to the mechano-biology of articular cartilage in health and disease [46,47,48,49].

1.4. Perlecan Operates at Several Functional Levels in Load-Bearing Connective Tissues

Relatively few studies have examined how perlecan impacts on the biomechanical properties of connective tissues. Perlecan binds type VI collagen in the chondron surrounding chondrocytes in cartilage and has cytoprotective properties [38] (Figure 2).
Perlecan also promotes co-acervation of tropoelastin and is found associated with fibrillin-1, LTBP-2 (latent TGF-β binding protein 2) and a number of accessory elastic proteins promoting the formation of elastic fibrils at the cell surface [38,51,52,53] (Figure 3 and Figure 4).
Perlecan-elastin and perlecan-elastin-type VI collagen structures contribute to the viscoelastic material properties of the composite IVD tissues, particularly the annulus fibrosus (AF) [57,58,59,60]. Fibrillin-1 and elastin fibrils are also prominent components of translamellar cross-bridge structures in the IVD which are internal stabilizing structures that interconnect multiple, collagen-rich lamellar layers and provideresiliency to this tissue [61,62]. Perlecan co-localises with elastin in a number of tissues and with type XI collagen in the PCM of chondrocytes and IVD cells, stabilizing this structure and providing mechanosensory properties [63] (Figure 5).
Perlecan interacts with α-dystroglycan in muscle tissues and has important roles in the assembly and function of the motor neuron neuromuscular junction (NMJ). It is a functional component of the specialized motor neuron synaptic endplate which interfaces with muscle fibres and controls muscular activity [65,66,67]. Perlecan also co-localises with elastin in endothelial cells in blood vessel basement membranes in vascularized tissues [54] (Figure 6).
From a biomechanical standpoint, the PCM appears to be defined similarly by the presence of type VI collagen as well as perlecan in both cartilage [43] and meniscus [68]. However, interior regions within the PCM containing both type VI collagen and perlecan exhibit lower elastic moduli than more peripheral regions that are rich in type VI collagen alone. The localization of perlecan to low modulus, interior regions of the PCM provides support for a potential role for HS and perlecan in the mechanical properties of the PCM as well as the process of mechanotransduction in cartilaginous tissues.
While the PCM is, in general, highly resistant to enzymatic digestion by chondroitinase, aggrecanase, or hyaluronidase [69], enzymatic removal of HS chains from perlecan with heparinase III results in increased elastic moduli in the PCM, specifically within interior regions of the PCM that are positive for both perlecan and type VI collagen. Interestingly, heparinase III digestion has no effect on the micromechanical properties of the ECM. These findings suggest that perlecan plays a biomechanical role in the PCM compartment, potentially serving as an additional “integrator” of the various matrix proteins focused on this region. Indeed, the fact that intact chondrons can be isolated from mice genetically lacking collagen VI suggests that additional matrix macromolecules such as perlecan are required to maintain the structural integrity of the PCM.

1.5. The Functional Attributes of Perlecan’s Five Domains

1.5.1. Domain-1

Perlecan interacts with several collagens and cell adhesive and structural glycoproteins aiding in the organization and stabilization of the ECM and cell-ECM interface. Many of the collagens (e.g., collagen types IV, XIII, XIV) interact prominently with perlecan within the basal lamina of blood vessels, the blood–brain barrier, membranous structures surrounding nerves in the peripheral and central nervous systems (PNS/CNS), the meninges surrounding brain and spinal cord, and around nerve bundles. Some of the collagens have specific HS binding sites (e.g., collagen types V, XI) and can be incorporated into heterofibrils with collagen types I and II and this may contribute to microfibril and fibril bundle assembly in tendons. Fine type XI collagen fibres localize with perlecan in the PCM around cells and may have stabilizing roles to play in this region [63]. Other ECM proteins, including PRELP (proline/arginine-rich end leucine-rich repeat protein), WARP (von Willebrand factor A domain-related protein), laminin, thrombospondin and fibronectin also have HS binding sites which contribute to the networking of these components in the ECM. Col 99 is a transmembrane collagen that is interactive with perlecan found in Caenorhabditis elegans. CollQ, a collagen-tailed form of acetylcholinesterase is anchored in the NMJ by perlecan and is essential for motor nerve functional properties at the nerve-muscle interface which regulates muscular movement and is wired into the CNS allowing co-ordination of the activity of different muscle groups to control skeletal movement. PRELP is a member of the SLRP family and acts as an anchorage point for perlecan in many basement membranes [70]. WARP is another perlecan-interactive protein that has stabilizing properties in specialized membranous tissues surrounding nerves [71]. Perlecan interacts with collagen type VI in the PCM of tensional and weight bearing connective tissues (e.g., cartilage, IVD and meniscus) where it provides compliant and cyto-protective properties [38,43]. Perlecan also aids in the co-acervation of tropoelastin at the cell surface and in the assembly of a fibrillin scaffold around these nascent molecular structures to form elastic microfibrils which provide mechanosensory properties to the cells they are attached to [54].

1.5.2. Domain II

Perlecan domain II binds fibrillin-1, lipoproteins, and lipids. Excessive build up of these components on endothelial cells at the luminal surface of blood vessels contributes to atherosclerotic plaque formation. This is balanced by the ability of perlecan to clear lipids from the blood stream and their endocytosis by the vessel endothelium. Domain II acts as a low-density lipoprotein (LDL) receptor and binds Wnt and hedgehog proteins which are lipid-modified proteins of limited solubility in aqueous media. This aids in the transport of these proteins and also facilitates formation of biochemical gradients that drive tissue development and morphogenesis.

1.5.3. Domain III

WARP binds to perlecan domain III. WARP has a restricted expression in the permanent cartilages and a distinct subset of basement membranes in peripheral nerves, muscle, and CNS vasculature. Besides binding to perlecan, WARP also binds to type VI collagen, and may act as a bridging structure between protein networks in connective tissues [71]. Collagen type VI also binds to perlecan domain III, as does tropoelastin, suggesting that this domain may promote the formation of elastic microfibrils with mechanosensory functions.

1.5.4. Domain IV

Human perlecan domain IV contains 21 immunoglobulin G repeats, sharing homology with NCAM, and it also contains a novel peptide sequence that supports cell adhesion, spreading and activation of the FAK (focal adhesion kinase) cell signaling pathway [72]. Domain IV is the largest of perlecan’s domains and it acts as a template for the attachment of a number of ECM-stabilising proteins including, nidogen-1 and 2, fibronectin and collagen types IV and VI, thus it has a prominent role to play in ECM stabilisation [73,74]. Domain IV is also susceptible to degradation by a number of MMPs and serine proteases. The domain IV fragmentation pattern evident in various stages of prostate cancer may have utility as a biomarker of disease progression [75]. It has also been suggested that degradation of domain IV converts it from a tumour-inhibitory form to one which is ‘tumour-friendly’ [76].

1.5.5. Domain V

Domain V is composed of three laminin G domains which are each separated by two EGF-like domains. Domain V interacts with a number of ECM-stabilising proteins (nidogen-1, fibulin-2, ECM-1, collagen type VI), however the major interest of domain V lies in its angiogenic properties which have been proposed as a prospective therapeutic to treat ischaemic stroke [77,78]. Fragments of domain V containing the LG1-LG2 domains or LG3 domain can block VEGFA (vascular endothelial growth factor A) activity or binding to α2β1 integrin providing anti-angiogenic activity. A GAG attachment site has also been identified in the LG3 domain but it is not always occupied [79].

1.6. Fibrillin-1 Stabilizes Tissues and Provides Essential Functional Properties

Fibrillin-1 is a fibrillar 350 kDa calcium-binding protein that has a widespread distribution in connective tissues occurring in assemblies of 10–12 nm microfibrils. Fibrillin 1-3 contain two types of disulfide-rich motifs, the calcium-binding epidermal growth factor-like (cbEGF) and transforming growth factor beta binding protein (TGFBP)-like domains as dominant functional determinants. Elastin and fibrillin-1 are building blocks for elastic fibers that support the mechanical stabilisation of tissues [80]. Fibrillin microfibrils provide biomechanical properties to tissues endowing them with limited elasticity and durability and these act as templates for elastin deposition during elastic fibre assembly [81]. Recent evidence suggests that tropoelastin initially undergoes assembly within the cell or at unique assembly sites on the plasma membrane to form elastin aggregates (Figure 3a,b), which, when outside the cell, transfer to fibrillin scaffolds-tensional forces transmitted through these structures then help to shape the growing microfibril [82] (Figure 4c,d). The recent identification of intracellular perlecan in IVD cells suggests potential roles in this aggregation process, and is consistent with roles ascribed to HS in the initial stages of the co-acervation of tropoelastin [83,84]. Knock-out studies in mice have also shown that accessory proteins such as fibulin-4, -5 and LTBP-4 also play crucial roles in the elastogenic process [85]. Elastic microfibrils also represent a storage niche for growth factors in tissues, mutations in fibrillin cause Marfan syndrome and short-stature pathologies due to dysregulated growth factor signalling. Thus while elastin-fibrillin microfibrils have mechanosensory roles in tissues they also have major regulatory functional roles in growth factor regulation [86] (Figure 4b).

1.7. Interactive Properties of Perlecan, Assembly of Elastic Microfibrils and Their Functional Attributes

Confocal studies have demonstrated that perlecan in the PCM of AF cells promotes the co-acervation of tropoelastin synthesised by this cell type [52,53,54]. A quartz crystal microbalance study also demonstrated the de novo assembly of elastin on a quartz crystal coated with perlecan in vitro [54]. Fibrillin-1 fibrils are also assembled at the AF cell surface surrounding the coacervated elastin to form a composite elastin-fibrillin fibril as found in many other connective tissue cell types (Figure 4c,d). These elastic fibrils are found co-distributed with collagen fibrils including type VI collagen and versican and are also attached to cell-associated perlecan in the annular tissues. Cells of the AF and nucleus pulposus of the IVD possess a PCM rich in type VI collagen, similar to that of articular cartilage, which plays a crucial role in the transmission of mechanical signals from the surrounding environment of the cells [87,88,89] (Figure 3). The AF undergoes both tension and compression in the composite IVD tissues. Perlecan also colocalizes with elastin and fibrillin-1 in blood vessels [54]. These observations are consistent with published studies identifying HS as a component of early microfibril assembly [84] and the linkage of fibrillin fibril bundles with other connective tissue networks by versican [90]. Fibronectin serves a similar role in the assembly of elastic fibrils with other cell types [91,92] and governs the deposition of LTBP in tissues [93]. Elastic microfibrils are not only structural determinants in tissues but also play mechanosensory roles that allow cells to maintain tissue homeostasis [94,95]. Elastic microfibrils are also repositories for growth factors that have roles in tissue development and morphogenesis [96,97]. The fibrillin microfibril scaffold contains a number of associated proteins and growth factors, e.g., transforming growth factor-β (TGF-β), bone morphogenetic proteins (BMPs) etc, thus these are mechano-responsive structures capable of feeding mechanosensory signals back to cellular receptors through the fibrillin fibril extracellular network [97,98,99]. This complex interchange of information regulates tissue homeostasis and development and growth [94,95,96]. Abnormal functioning of this system is evident in Marfan’s Syndrome and other pathological conditions of short stature.

1.8. The Pericellular Matrix, a Dynamic Cell-Matrix Interface

The PCM is a key region in tissues, representing an interactive interface between cells and their biomechanical micro-environment [100]. The PCM also protects cells in hostile weight-bearing environments [63,101]. Perlecan plays essential cyto-protective roles in the PCM as perlecan knockdown severely impacts PCM organisation, composition and functional properties [102] (Figure 2c,d). A structurally impaired PCM results in mechanical overload to the chondrocyte and cell death [103]. Loss of spatial organisation and destruction of the PCM in articular cartilage occurs in osteoarthritis (OA) [104] and is a hallmark of the degenerative processes that lead to the development of this joint disease [105,106]. Micromechanical mapping of early changes in the chondrocyte PCM in OA, atomic force microscopy (AFM) [107,108] and multiphoton microscopy [109] have demonstrated the importance of the correct structural organisation and mechanotransductive pathways in chondrocyte regulation in the maintenance of tissue homeostasis [110,111,112]. Perlecan interacts with collagen types VI and XI and a number of cell adhesive and structural glycoproteins to stabilise the PCM of the chondrocyte [32,38,63,113], and enzymatic digestion of perlecan alters the biomechanical properties of its PCM [43]. Perlecan is also a component of basal laminar structures and blood vessels in the synovium and paraspinal tissues (Figure 6). Confocal reconstructions of AF cells and articular chondrocytes labelled for perlecan and collagen type VI show the overlapping pericellular localisations of perlecan and collagen type VI within the chondron structure (Figure 3e). While perlecan has a pericellular distribution around chondrocytes in the rudiment and growth plate cartilages it also has an extracellular distribution in these tissues during morphogenetic change with tissue development. This contrasts with the highly focussed PCM distribution of perlecan around articular chondrocytes of mature cartilage tissues, i.e., with no detectable perlecan within the interstitial and inter-territorial ECM, as once formed, these permanent cartilages, once formed, do not undergo further morphogenesis (Figure 2c,d). Perlecan is also found in translamellar cross bridge structures within the IVD having a polarized distribution at the ends of strings of fusiform AF (Figure 3) and ligament cells and being surrounded by linear arrays of fibrillar collagen. Furthermore, in the meniscus, perlecan has PCM and ECM distributions similar to that of chondrocytes found in growth plate cartilage [114]. Thus, as the precise spatio-temporal distribution of perlecan differs in particular cartilaginous tissues, its realms of influence varies accordingly.

1.9. Elastic Networks in Load-Bearing Connective Tissues

As mentioned above, perlecan interacts with a number of ECM components to stabilize tensional and weight bearing tissues such as articular cartilage and IVD. Perlecan interacts with fibrillin-1 and elastin in the AF of the IVD (Figure 7) and in translamellar cross-bridge structures across many lamellar layers [62] (Figure 5). Type VI collagen is also a prominent component of these structures and has been shown to interact with perlecan associated with elastic microfibrils [38,61].
While elastin is a well-known component of tissues such as lung and blood vessels, endowing these tissues with the elasticity necessary for their physiological functions, recent research has also revealed the existence of extensive networks of fine elastin fibres in tissues such as articular cartilage and the IVD [115,116]. Microfibrillar elastic networks are evident in bovine and human IVDs. In the outer AF of the IVD, these are organized into parallel microfibril bundles in the interterritorial matrix, co-localized with elastin fibres and aligned parallel to collagen fibres [116]. Fibrillin-1, fibrillin-2 and LTBP-2 are also found associated with these fibrillar networks [117] and contribute to the mechanical properties of these structures (Figure 7). An elastin rich basal lamina is also present in the endothelium of the knee joint (Figure 8).
The importance of microfibrillar elastic networks in biomechanical function can be seen across musculoskeletal connective tissues of different organisms and joints. Figure 9 shows elastin fibres distributed in kangaroo knee tibial articular cartilage [118,119]. The kangaroo is a high-performance athletic animal that can maintain a comfortable hopping speed of between 20 to 25 km/h but it can move at speeds of up to 70 km/h over short distances, and can maintain a speed of 40 km/h for nearly 2 km. Thus, the elastic fibres observed in kangaroo knee articular cartilage are expected to make a significant mechanical contribution to the rebound performance of its articular cartilages. Femoro-tibial kangaroo cartilages also have well defined collagen fibre networks which contribute to the high mechanical performance of these tissues [120]. Extensive elastic fibrillary networks are also present in bovine articular cartilage, which is a more sedentary animal [121]. Temporomandibular cartilage also has an extensive arrangement of elastic fibres and these are even found in flexor tendon [122,123,124], a tissue considered to be inextensible and designed for force transmission. Elastic fibres are also major components of the deformable elastic cartilages found in the outer ear (pinna), nose, larynx, trachea, ligaments and vascular endothelium and contribute significantly to their flexibility.
Correlation of the type VI collagen and perlecan immunolocalization patterns around articular chondrocytes (Figure 10) and meniscal cells (Figure 11) with focal biomechanical data obtained from AFM show that both molecules contribute to the biomechanical functional properties of these tissues (i.e., articular cartilage and meniscus). The elastic fibrils present in these tissues would also be expected to have roles in their resilience and visco-elastic properties, thus complimenting those of perlecan and collagen type VI. This study demonstrates that perlecan and elastin co-localise in many connective tissues and that type VI collagen fibres are frequently deposited parallel to the elastin fibres (Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8 and Figure 10). This suggests the likelihood of cooperative interactions between these components in order to facilitate the demanding material properties required to resist tensional and compressive biomechanical loads.

2. Conclusions

A vast amount of literature has elucidated perlecan’s roles as a vascular HS-PG. However, with the identification of perlecan in non-vascularised tissues, such as articular cartilage, meniscus, and IVD, its roles in ECM organization and stabilization in tensional and weight-bearing connective tissues has become apparent. ECM networks assembled by cells consisting of perlecan-elastin and perlecan-elastin-collagen type VI assembled by cells are both strong and compliant and contribute to the visco-elastic material properties of tensional and weight-bearing connective tissues. Perlecan is an important component of the PCM and has roles in the assembly and function of structures which connect the cell with its pericellular microenvironment. The PCM is a mechanosensory structure that provides cues to cells which respond appropriately to fluctuations in their microenvironment to maintain tissue homeostasis. Perlecan facilitates the coacervation of tropoelastin and its incorporation with fibrillin-1 in elastic microfibrils at the cell surface. Perlecan also co-localizes with elastin in blood vessels and in the endothelium of synovial joints and has interactive properties with the collagen types VI and XI networks in the PCM of articular cartilage and IVD. Data suggests that perlecan provides a level of compliance to the relatively rigid collagen type VI chondron structure and confers a cytoprotective property. Perlecan is an outstandingly versatile PG in terms of the numbers of physiological processes it regulates and the important functional roles it plays in a variety of different connective tissues. The mechanosensory and neurosensory processes outlined in this review illustrate another chapter in the functional repertoire of this fascinating multifunctional HS-PG.

Author Contributions

Conceptualisation F.G., A.J.H., J.M.; Writing-original draft preparation, J.M.; writing and editing, F.G., A.J.H., J.M.; funding acquisition, F.G., J.M.; All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded in part by National Institutes of Health Grants AG15768, AG46027, and AR072999 and NHMRC Project grant 512167. The 3D rendering software used in this study for reconstruction of confocal datasets (Imaris for Cell Biologists, Oxford Instruments) was purchased through Cardiff University’s research infrastructure fund.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All pertinent data are presented within this manuscript.

Conflicts of Interest

The authors have no financial disclosures to make or conflicts to report. The funding agencies listed had no input into experimental design or the final form of the manuscript.

References

  1. Melrose, J.; Hayes, A.J.; Whitelock, J.M.; Little, C.B. Perlecan, the “jack of all trades” proteoglycan of cartilaginous weight-bearing connective tissues. Bioessays 2008, 30, 457–469. [Google Scholar] [CrossRef] [PubMed]
  2. Knox, S.M.; Whitelock, J.M. Perlecan: How does one molecule do so many things? Cell Mol. Life Sci. 2006, 63, 2435–2445. [Google Scholar] [CrossRef] [PubMed]
  3. Knox, S.; Fosang, A.J.; Last, K.; Melrose, J.; Whitelock, J. Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycan. FEBS Lett. 2005, 579, 5019–5023. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Jung, M.; Lord, M.S.; Cheng, B.; Lyons, J.G.; Alkhouri, H.; Hughes, J.M.; McCarthy, S.J.; Iozzo, R.V.; Whitelock, J.M. Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: A role in angiogenesis and wound healing. J. Biol. Chem. 2013, 288, 3289–3304. [Google Scholar] [CrossRef] [Green Version]
  5. Rnjak-Kovacina, J.; Tang, F.; Lin, X.; Whitelock, J.M.; Lord, M.S. Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan. Biotechnol. J. 2017, 12, 196. [Google Scholar] [CrossRef]
  6. Siegel, G.; Malmsten, M.; Ermilov, E. Anionic biopolyelectrolytes of the syndecan/perlecan superfamily: Physicochemical properties and medical significance. Adv. Colloid Interface Sci. 2014, 205, 275–318. [Google Scholar] [CrossRef] [PubMed]
  7. Gradilla, A.C.; Sanchez-Hernandez, D.; Brunt, L.; Scholpp, S. From top to bottom: Cell polarity in Hedgehog and Wnt trafficking. BMC Biol. 2018, 16, 37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Saha, S.; Nagy, T.L.; Weiner, O.D. Joining forces: Crosstalk between biochemical signalling and physical forces orchestrates cellular polarity and dynamics. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2018, 373, 20170145. [Google Scholar] [CrossRef] [Green Version]
  9. Thakore, P.; Earley, S. Transient Receptor Potential Channels and Endothelial Cell Calcium Signaling. Compr. Physiol. 2019, 9, 1249–1277. [Google Scholar]
  10. Ottolini, M.; Hong, K.; Sonkusare, S.K. Calcium signals that determine vascular resistance. Wiley Interdiscip. Rev. Syst. Biol. Med. 2019, 11, e1448. [Google Scholar] [CrossRef]
  11. Thompson, W.; Modla, S.; Grindel, B.J.; Czymmek KJKirn-Safran, C.B.; Wang, L.; Duncan, R.L.; Farach-Carson, M.C. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J. Bone Miner Res. 2011, 26, 618–629. [Google Scholar] [CrossRef] [Green Version]
  12. Wang, B.; Lai, X.; Price, C.; Thompson, W.R.; Li, W.; Quabili, T.R.; Tseng, W.J.; Liu, X.S.; Zhang, H.; Pan, J.; et al. Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system. J. Bone Miner Res. 2014, 29, 878–891. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Wang, L. Solute Transport in the Bone Lacunar-Canalicular System (LCS). Curr. Osteoporos. Rep. 2018, 16, 32–41. [Google Scholar] [CrossRef]
  14. Mow, V.; Bachrach, N.M.; Setton, L.A.; Guilak, F. Stress, Strain, Pressure and Flow Fields in Articular Cartilage and Chondrocytes. In Cell Mechanics and Cellular Engineering; Mow, V.C., Tran-Son-Tay, R., Guilak, F., Hochmuth, R.M., Eds.; Springer LLC: New York, NY, USA, 1994; pp. 345–379. [Google Scholar]
  15. Haider, M.; Schugart, R.C.; Setton, L.A.; Guilak, F. A mechano-chemical model for the passive swelling response of an isolated chondron under osmotic loading. Biomech. Model. Mechanobiol. 2006, 5, 160–171. [Google Scholar] [CrossRef]
  16. Maroudas, A. Physicochemical Properties of Articular Cartilage. In Adult Articular Cartilage; Mar, F., Ed.; Pitman Medical: Bath, UK, 1979; pp. 215–290. [Google Scholar]
  17. Urban, J.; Hall, A.C.; Gehl, K.A. Regulation of matrix synthesis rates by the ionic and osmotic environment of articular chondrocytes. J. Cell Physiol. 1993, 154, 262–270. [Google Scholar] [CrossRef]
  18. Urban, J. The chondrocyte: A cell under pressure. Br. J. Rheumatol. 1994, 33, 901–908. [Google Scholar] [CrossRef]
  19. Jeremiasse, B.; Matta, C.; Fellows, C.R.; Boocock, D.J.; Smith, J.R.; Liddell, S.; Lafeber, F.; van Spil, W.E.; Mobasheri, A. Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines. BMC Mol. Cell Biol. 2020, 21, 47. [Google Scholar] [CrossRef] [PubMed]
  20. Lewis, R.; May, H.; Mobasheri, A.; Barrett-Jolley, R. Chondrocyte channel transcriptomics: Do microarray data fit with expression and functional data? Channels 2013, 7, 459–467. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Maleckar, M.; Martin-Vasallo, P.; Giles, W.R.; Mobasheri, A. Physiological Effects of the Electrogenic Current Generated by the Na+/K+ Pump in Mammalian Articular Chondrocytes. Bioelectricity 2020, 2, 2020. [Google Scholar] [CrossRef]
  22. Mobasheri, A.; Mobasheri, R.; Francis, M.J.; Trujillo, E.; Alvarez de la Rosa, D.; Martín-Vasallo, P. Ion transport in chondrocytes: Membrane transporters involved in intracellular ion homeostasis and the regulation of cell volume, free [Ca2+] and pH. Histol. Histopathol. 1998, 13, 893–910. [Google Scholar] [PubMed]
  23. Mobasheri, A.; Matta, C.; Uzieliene, I.; Budd, E.; Martín-Vasallo, P.; Bernotiene, E. The chondrocyte channelome: A narrative review. Jt. Bone Spine 2019, 86, 29–35. [Google Scholar] [CrossRef]
  24. Lee, W.; Leddy, H.A.; Chen, Y.; Lee, S.H.; Zelenski, N.A.; McNulty, A.L.; Wu, J.; Beicker, K.N.; Coles, J.; Zauscher, S.; et al. Synergy between Piezo1 and Piezo2 channels confers high-strain mechanosensitivity to articular cartilage. Proc. Natl. Acad. Sci. USA 2014, 111, E5114–E5122. [Google Scholar] [CrossRef] [Green Version]
  25. Phan, M.; Leddy, H.A.; Votta, B.J.; Kumar, S.; Levy, D.S.; Lipshutz, D.B.; Lee, S.H.; Liedtke, W.; Guilak, F. Functional characterization of TRPV4 as an osmotically sensitive ion channel in porcine articular chondrocytes. Arthritis Rheumatol. 2009, 60, 3028–3037. [Google Scholar] [CrossRef] [Green Version]
  26. Mobasheri, A. Regulation of Na+, K+-ATPase density by the extracellular ionic and osmotic environment in bovine articular chondrocytes. Physiol. Res. 1999, 45, 509–512. [Google Scholar]
  27. Mobasheri, A.; Avila, J.; Co´zar-Castellano, I.; Brownleader, M.D.; Trevan, M.; Francis, M.J.; Lamb, J.F.; Martín-Vasallo, P. Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci. Rep. 2000, 20, 51–91. [Google Scholar] [CrossRef] [PubMed]
  28. Mobasheri, A.; Errington, R.J.; Golding, S.; Hall, A.C.; Urban, J.P. Characterization of the Na+, K(+)-ATPase in isolated bovine articular chondrocytes; molecular evidence for multiple alpha and beta isoforms. Cell Biol. Int. 1997, 21, 212–301. [Google Scholar] [CrossRef] [PubMed]
  29. Mobasheri, A.; Hall, A.C.; Urban, J.P.; France, S.J.; Smith, A.L. Immunologic and autoradiographic localisation of the Na+, K(+)-ATPase in articular cartilage: Upregulation in response to changes in extracellular Na+ concentration. Int. J. Biochem. Cell Biol. 1997, 29, 649–657. [Google Scholar] [CrossRef]
  30. Trujillo, E.; de la Rosa, D.A.; Mobasheri, A.; Avila, J.; González, T.; Martín-Vasallo, P. Sodium transport systems in human chondrocytes. I. Morphological and functional expression of the Na+,K(+)- ATPase alpha and beta subunit isoforms in healthy and arthritic chondrocytes. Histol. Histopathol. 1999, 14, 1011–1022. [Google Scholar]
  31. Erickson, G.; Northrup, D.; Guilak, F. Hypo-osmotic stress induces calcium-dependent actin reorganization in articular chondrocytes. Osteoarth. Cartil. 2003, 11, 187–197. [Google Scholar] [CrossRef] [Green Version]
  32. Zelenski, N.; Leddy, H.A.; Sanchez-Adams, J.; Zhang, J.; Bonaldo, P.; Liedtke, W.; Guilak, F. Type VI Collagen Regulates Pericellular Matrix Properties, Chondrocyte Swelling, and Mechanotransduction in Mouse Articular Cartilage. Arthritis Rheumatol. 2015, 67, 1286–1294. [Google Scholar] [CrossRef] [Green Version]
  33. Gilchrist, C.; Leddy, H.A.; Kaye, L.; Case, N.D.; Rothenberg, K.E.; Little, D.; Liedtke, W.; Hoffman, B.D.; Guilak, F. TRPV4-mediated calcium signaling in mesenchymal stem cells regulates aligned collagen matrix formation and vinculin tension. Proc. Natl. Acad. Sci. USA 2019, 116, 1992–1997. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Vincent, T.; Saklatvala, J. Basic fibroblast growth factor: An extracellular mechanotransducer in articular cartilage? Biochem. Soc. Trans. 2006, 34, 456–457. [Google Scholar] [CrossRef]
  35. Vincent, T.; McLean, C.J.; Full, L.E.; Peston, D.; Saklatvala, J. FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer. Osteoarthr. Cartil. 2007, 15, 752–763. [Google Scholar] [CrossRef] [Green Version]
  36. Danalache, M.; Kleinert, R.; Schneider, J.; Erler, A.L.; Schwitalle, M.; Riester, R.; Traub, F.; Hofmann, U.K. Changes in stiffness and biochemical composition of the pericellular matrix as a function of spatial chondrocyte organisation in osteoarthritic cartilage. Osteoarthr. Cartil. 2019, 27, 823–832. [Google Scholar] [CrossRef] [PubMed]
  37. Wiberg, C.; Hedbom, E.; Khairullina, A.; Lamande, S.R.; Oldberg, A.; Timpl, R.; Morgelin, M.; Heinegard, D. Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J. Biol. Chem. 2001, 276, 18947–18952. [Google Scholar] [CrossRef] [Green Version]
  38. Hayes, A.J.; Shu, C.C.; Lord, M.S.; Little, C.B.; Whitelock, J.M.; Melrose, J. Pericellular colocalisation and interactive properties of type VI collagen and perlecan in the intervertebral disc. Eur. Cell Mater. 2016, 32, 40–57. [Google Scholar] [CrossRef] [Green Version]
  39. Melrose, J.; Isaacs, M.D.; Smith, S.M.; Hughes, C.E.; Little, C.B.; Caterson, B.; Hayes, A.J. Chondroitin sulphate and heparan sulphate sulphation motifs and their proteoglycans are involved in articular cartilage formation during human foetal knee joint development. Histochem. Cell Biol. 2012, 138, 461–475. [Google Scholar] [CrossRef] [PubMed]
  40. Melrose, J.; Roughley, P.; Knox, S.; Smith, S.; Lord, M.; Whitelock, J. The structure, location, and function of perlecan, a prominent pericellular proteoglycan of fetal, postnatal, and mature hyaline cartilages. J. Biol. Chem. 2006, 281, 36905–36914. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Melrose, J.; Shu, C.; Whitelock, J.M.; Lord, M.S. The cartilage extracellular matrix as a transient developmental scaffold for growth plate maturation. Matrix Biol. 2016, 52–54, 363–383. [Google Scholar] [CrossRef] [PubMed]
  42. Smith, S.M.; Shu, C.; Melrose, J. Comparative immunolocalisation of perlecan with collagen II and aggrecan in human foetal, newborn and adult ovine joint tissues demonstrates perlecan as an early developmental chondrogenic marker. Histochem. Cell Biol. 2010, 134, 251–263. [Google Scholar] [CrossRef] [PubMed]
  43. Wilusz, R.E.; Defrate, L.E.; Guilak, F. A biomechanical role for perlecan in the pericellular matrix of articular cartilage. Matrix Biol. 2012, 31, 320–327. [Google Scholar] [CrossRef] [Green Version]
  44. Chery, D.; Han, B.; Zhou, Y.; Wang, C.; Adams, S.M.; Chandrasekaran, P.; Kwok, B.; Heo, S.J.; Enomoto-Iwamoto, M.; Lu, X.L.; et al. Decorin Regulates Cartilage Pericellular Matrix Micromechanobiology. Matrix Biol. 2021, 96, 1–7. [Google Scholar] [CrossRef] [PubMed]
  45. Han, B.; Li, Q.; Wang, C.; Patel, P.; Adams, S.M.; Doyran, B.; Nia, H.T.; Oftadeh, R.; Zhou, S.; Li, C.Y.; et al. Decorin Regulates the Aggrecan Network Integrity and Biomechanical Functions of Cartilage Extracellular Matrix. ACS Nano 2019, 13, 11320–11333. [Google Scholar] [CrossRef] [PubMed]
  46. Bilton, M.; Thambyah, A.; Clarke, R.J. How changes in interconnectivity affect the bulk properties of articular cartilage: A fibre network study. Biomech. Model. Mechanobiol. 2018, 17, 1297–1315. [Google Scholar] [CrossRef]
  47. Ebrahimi, M.; Ojanen, S.; Mohammadi, A.; Finnilä, M.A.; Joukainen, A.; Kröger, H.; Saarakkala, S.; Korhonen, R.K.; Tanska, P. Elastic, Viscoelastic and Fibril-Reinforced Poroelastic Material Properties of Healthy and Osteoarthritic Human Tibial Cartilage. Ann. Biomed. Eng. 2019, 47, 953–966. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Gottardi, R.; Hansen, U.; Raiteri, R.; Loparic, M.; Düggelin, M.; Mathys, D.; Friederich, N.F.; Bruckner, P.; Stolz, M. Supramolecular Organization of Collagen Fibrils in Healthy and Osteoarthritic Human Knee and Hip Joint Cartilage. PLoS ONE 2016, 11, e0163552. [Google Scholar] [CrossRef] [PubMed]
  49. Nickien, M.; Thambyah, A.; Broom, N.D. How a decreased fibrillar interconnectivity influences stiffness and swelling properties during early cartilage degeneration. J. Mech. Behav. Biomed. Mater. 2017, 75, 390–398. [Google Scholar] [CrossRef]
  50. Melrose, J.; Smith, S.; Cake, M.; Read, R.; Whitelock, J. Perlecan displays variable spatial and temporal immunolocalisation patterns in the articular and growth plate cartilages of the ovine stifle joint. Histochem. Cell Biol. 2005, 123, 561–571. [Google Scholar] [CrossRef]
  51. Hayes, A.J.; Gibson, M.A.; Shu, C.; Melrose, J. Confocal microscopy demonstrates association of LTBP-2 in fibrillin-1 microfibrils and colocalisation with perlecan in the disc cell pericellular matrix. Tissue Cell 2014, 46, 185–197. [Google Scholar] [CrossRef]
  52. Hayes, A.J.; Smith, S.M.; Gibson, M.A.; Melrose, J. Comparative immunolocalization of the elastin fiber-associated proteins fibrillin-1, LTBP-2, and MAGP-1 with components of the collagenous and proteoglycan matrix of the fetal human intervertebral disc. Spine 2011, 36, E1365–E1372. [Google Scholar] [CrossRef]
  53. Hayes, A.J.; Smith, S.M.; Melrose, J. Comparative immunolocalisation of fibrillin-1 and perlecan in the human foetal, and HS-deficient hspg2 exon 3 null mutant mouse intervertebral disc. Histochem. Cell Biol. 2013, 139, 1–11. [Google Scholar] [CrossRef]
  54. Hayes, A.J.; Lord, M.S.; Smith, S.M.; Smith, M.M.; Whitelock, J.M.; Weiss, A.S.; Melrose, J. Colocalization in vivo and association in vitro of perlecan and elastin. Histochem. Cell Biol. 2011, 136, 437–454. [Google Scholar] [CrossRef] [PubMed]
  55. Montes, G. Structural biology of the fibres of the collagenous and elastic systems. Cell Biol. Int. 1996, 20, 15–27. [Google Scholar] [CrossRef] [PubMed]
  56. Engvall, E.; Hessle, H.; Klier, G. Molecular assembly, secretion, and matrix deposition of type VI collagen. J. Cell Biol. 1986, 102, 703–710. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Fearing, B.; Hernandez, P.A.; Setton, L.A.; Chahine, N.O. Mechanotransduction and cell biomechanics of the intervertebral disc. JOR Spine 2018, 1, e1026. [Google Scholar] [CrossRef] [PubMed]
  58. Hickey, D.; Hukins, D.W. Relation between the structure of the annulus fibrosus and the function and failure of the intervertebral disc. Spine 1980, 5, 106–116. [Google Scholar] [CrossRef] [PubMed]
  59. Molladavoodi, S.; McMorran, J.; Gregory, D. Mechanobiology of annulus fibrosus and nucleus pulposus cells in intervertebral discs. Cell Tissue Res. 2020, 379, 429–444. [Google Scholar] [CrossRef] [PubMed]
  60. Tavakoli, J.; Elliott, D.M.; Costi, J.J. Structure and mechanical function of the inter-lamellar matrix of the annulus fibrosus in the disc. J. Orthop. Res. 2016, 34, 1307–1315. [Google Scholar] [CrossRef] [PubMed]
  61. Melrose, J.; Smith, S.M.; Appleyard, R.C.; Little, C.B. Aggrecan, versican and type VI collagen are components of annular translamellar crossbridges in the intervertebral disc. Eur. Spine J. 2008, 17, 314–324. [Google Scholar] [CrossRef] [Green Version]
  62. Yu, J.; Schollum, M.L.; Wade, K.R.; Broom, N.D.; Urban, J.P. ISSLS Prize Winner: A Detailed Examination of the Elastic Network Leads to a New Understanding of Annulus Fibrosus Organization. Spine 2015, 40, 1149–1157. [Google Scholar] [CrossRef] [PubMed]
  63. Smith, S.; Melrose, J. Type XI collagen-perlecan-HS interactions stabilise the pericellular matrix of annulus fibrosus cells and chondrocytes providing matrix stabilisation and homeostasis. J. Mol. Histol. 2019, 50, 285–294. [Google Scholar] [CrossRef] [PubMed]
  64. Warner, L.; Brown, R.J.; Yingst, S.M.; Oxford, J.T. Isoform-specific heparan sulfate binding within the amino-terminal noncollagenous domain of collagen alpha1(XI). J. Biol. Chem. 2006, 281, 39507–39516. [Google Scholar] [CrossRef] [Green Version]
  65. Ida-Yonemochi, H.; Ahsan, M.S.; Saku, T. Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: Two possible perlecan signalling pathways for cellular growth and differentiation. Histopathology 2011, 58, 234–245. [Google Scholar] [CrossRef]
  66. Kamimura, K.; Ueno, K.; Nakaawa, J.; Hamada, R.; Saitoe, M.; Maeda, N. Perlecan regulates bidirectional Wnt signaling at the Drosophila neuromuscular junction. J. Cell Biol. 2013, 200, 219–233. [Google Scholar] [CrossRef] [Green Version]
  67. Singhal, N.; Martin, P.T. Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction. Dev. Neurobiol. 2011, 71, 982–1005. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Sanchez-Adams, J.; Wilusz, R.E.; Guilak, F. Atomic force microscopy reveals regional variations in the micromechanical properties of the pericellular and extracellular matrices of the meniscus. J. Orthop. Res. 2013, 31, 1218–1225. [Google Scholar] [CrossRef] [Green Version]
  69. Wilusz, R.; Guilak, F. High resistance of the mechanical properties of the chondrocyte pericellular matrix to proteoglycan digestion by chondroitinase, aggrecanase, or hyaluronidase. J. Mech. Behav. Biomed. Mater. 2014, 38, 183–197. [Google Scholar] [CrossRef] [Green Version]
  70. Bengtsson, E.; Mörgelin, M.; Sasaki, T.; Timpl, R.; Heinegård, D.; Aspberg, A. The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J. Biol. Chem. 2002, 277, 15061–15068. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Allen, J.; Zamurs, L.; Brachvogel, B.; Schlötzer-Schrehardt, U.; Hansen, U.; Lamandé, S.R.; Rowley, L.; Fitzgerald, J.; Bateman, J.F. Mice lacking the extracellular matrix protein WARP develop normally but have compromised peripheral nerve structure and function. J. Biol. Chem. 2009, 284, 12020–12030. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Farach-Carson, M.; Brown, A.J.; Lynam, M.; Safran, J.B.; Carson, D.D. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation. Matrix Biol. 2008, 27, 150–160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Murdoch, A.; Dodge, G.R.; Cohen, I.; Tuan, R.S.; Iozzo, R.V. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem. 1992, 267, 8544–8557. [Google Scholar]
  74. Noonan, D.; Fulle, A.; Valente, P.; Cai, S.; Horigan, E.; Sasaki, M.; Yamada, Y.; Hassell, J.R. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 1991, 266, 22939–22947. [Google Scholar] [CrossRef]
  75. Grindel, B.; Li, Q.; Arnold, R.; Petros, J.; Zayzafoon, M.; Muldoon, M.; Stave, J.; Chung, L.W.; Farach-Carson, M.C. Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: Tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients. Oncotarget 2016, 7, 10433–40447. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Cruz, L.; Tellman, T.V.; Farach-Carson, M.C. Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment. Adv. Exp. Med. Biol. 2020, 1245, 133–146. [Google Scholar] [PubMed]
  77. Bix, G. Perlecan domain V therapy for stroke: A beacon of hope? ACS Chem. Neurosci. 2013, 4, 370–374. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  78. Trout, A.; Kahle, M.P.; Roberts, J.M.; Marcelo, A.; de Hoog, L.; Boychuk, J.A.; Grupke, S.L.; Berretta, A.; Gowing, E.K.; Boychuk, C.R.; et al. Perlecan Domain-V Enhances Neurogenic Brain Repair After Stroke in Mice. Transl. Stroke Res. 2020, 12, 72–86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Tapanadechopone, P.; Hassell, J.R.; Rigatti, B.; Couchman, J.R. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan. Biochem. Biophys. Res. Commun. 1999, 265, 680–690. [Google Scholar] [CrossRef]
  80. Kielty, C. Fell-Muir Lecture: Fibrillin microfibrils: Structural tensometers of elastic tissues? Int. J. Exp. Pathol. 2017, 98, 172–190. [Google Scholar] [CrossRef] [Green Version]
  81. Godwin, A.; Singh, M.; Lockhart-Cairns, M.P.; Alanazi, Y.F.; Cain, S.A.; Baldock, C. The role of fibrillin and microfibril binding proteins in elastin and elastic fibre assembly. Matrix Biol. 2019, 84, 17–30. [Google Scholar] [CrossRef]
  82. Kozel, B.; Mecham, R.P. Elastic fiber ultrastructure and assembly. Matrix Biol. 2019, 84, 31–40. [Google Scholar] [CrossRef]
  83. Hayes, A.; Melrose, J. 3D Distribution of Perlecan within Intervertebral Disc Chondrons Suggests Novel Regulatory Roles for this Multifunctional Modular Heparan Sulphate Proteoglycan. Eur. Cells Mater. 2020, 41, 73–89. [Google Scholar] [CrossRef]
  84. Yadin, D.; Robertson, I.B.; McNaught-Davis, J.; McNaught-Davis, J.; Evans, P.; Stoddart, D.; Handford, P.A.; Jensen, S.A.; Redfield, C. Structure of the fibrillin-1 N-terminal domains suggests that heparan sulfate regulates the early stages of microfibril assembly. Structure 2013, 21, 1743–1756. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Shin, S.; Yanagisawa, H. Recent updates on the molecular network of elastic fiber formation. Essays Biochem. 2019, 63, 365–376. [Google Scholar]
  86. Thomson, J.; Singh, M.; Eckersley, A.; Cain, S.A.; Sherratt, M.J.; Baldock, C. Fibrillin microfibrils and elastic fibre proteins: Functional interactions and extracellular regulation of growth factors. Semin. Cell Dev. Biol. 2019, 89, 109–117. [Google Scholar] [CrossRef]
  87. Cao, L.; Guilak, F.; Setton, L.A. Three-dimensional morphology of the pericellular matrix of intervertebral disc cells in the rat. J. Anat. 2007, 211, 444–452. [Google Scholar] [CrossRef] [PubMed]
  88. Cao, L.; Guilak, F.; Setton, L.A. Pericellular Matrix Mechanics in the Anulus Fibrosus Predicted by a Three-Dimensional Finite Element Model and In Situ Morphology. Cell Mol. Bioeng. 2009, 2, 306–319. [Google Scholar] [CrossRef] [Green Version]
  89. Cao, L.; Guilak, F.; Setton, L.A. Three-dimensional finite element modeling of pericellular matrix and cell mechanics in the nucleus pulposus of the intervertebral disk based on in situ morphology. Biomech. Model. Mechanobiol. 2011, 10, 1–10. [Google Scholar] [CrossRef] [Green Version]
  90. Isogai, Z.; Aspberg, A.; Keene, D.R.; Ono, R.N.; Reinhardt, D.P.; Sakai, L.Y. Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J. Biol. Chem. 2002, 277, 4565–4572. [Google Scholar] [CrossRef] [Green Version]
  91. Kinsey, R.; Williamson, M.R.; Chaudhry, S.; Mellody, K.T.; McGovern, A.; Takahashi, S.; Shuttleworth, C.A.; Kielty, C.M. Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. J. Cell Sci. 2008, 121, 2696–2704. [Google Scholar] [CrossRef] [Green Version]
  92. Sabatier, L.; Djokic, J.; Fagotto-Kaufmann, C.; Chen, M.; Annis, D.S.; Mosher, D.F.; Reinhardt, D.P. Complex contributions of fibronectin to initiation and maturation of microfibrils. Biochem. J. 2013, 456, 283–295. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Massam-Wu, T.; Chiu, M.; Choudhury, R.; Chaudhry, S.S.; Baldwin, A.K.; McGovern, A.; Baldock, C.; Shuttleworth, C.A.; Kielty, C.M. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta. J. Cell Sci. 2010, 123, 3006–3018. [Google Scholar] [CrossRef] [Green Version]
  94. Ramirez, F.; Dietz, H.C. Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events. J. Cell Physiol. 2007, 213, 326–330. [Google Scholar] [CrossRef] [PubMed]
  95. Ramirez, F.; Carta, L.; Lee-Arteaga, S.; Liu, C.; Nistala, H.; Smaldone, S. Fibrillin-rich microfibrils—Structural and instructive determinants of mammalian development and physiology. Connect. Tissue Res. 2008, 49, 1–6. [Google Scholar] [CrossRef]
  96. Ramirez, F.; Rifkin, D.B. Extracellular microfibrils: Contextual platforms for TGFbeta and BMP signaling. Curr. Opin. Cell Biol. 2009, 21, 616–622. [Google Scholar] [CrossRef] [Green Version]
  97. Sengle, G.; Sakai, L.Y. The fibrillin microfibril scaffold: A niche for growth factors and mechanosensation? Matrix Biol. 2015, 47, 3–12. [Google Scholar] [CrossRef] [PubMed]
  98. Hubmacher, D.; Apte, S.S. The biology of the extracellular matrix: Novel insights. Curr. Opin. Rheumatol. 2013, 25, 65–70. [Google Scholar] [CrossRef] [Green Version]
  99. Halper, J.; Kjaer, M. Basic components of connective tissues and extracellular matrix: Elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. Adv. Exp. Med. Biol. 2014, 802, 31–47. [Google Scholar] [PubMed]
  100. Wilusz, R.; Sanchez-Adams, J.; Guilak, F. The structure and function of the pericellular matrix of articular cartilage. Matrix Biol. 2014, 39, 25–32. [Google Scholar] [CrossRef]
  101. Liu, C.; Wang, B.; Xiao, L.; Li, Y.; Xu, L.; Zhao, Z.; Zhang, L. Protective effects of the pericellular matrix of chondrocyte on articular cartilage against the development of osteoarthritis. Histol. Histopathol. 2018, 33, 757–764. [Google Scholar]
  102. Ocken, A.; Ku, M.M.; Kinzer-Ursem, T.L.; Calve, S. Perlecan knockdown significantly alters extracellular matrix composition and organization during cartilage development. Mol. Cell Proteom. 2020, 19, 1220–1235. [Google Scholar] [CrossRef] [PubMed]
  103. Hofmann, U.; Steidle, J.; Danalache, M.; Bonnaire, F.; Walter, C.; Rolauffs, B. Chondrocyte death after mechanically overloading degenerated human intervertebral disk explants is associated with a structurally impaired pericellular matrix. J. Tissue Eng. Regen. Med. 2018, 12, 2000–2010. [Google Scholar] [CrossRef] [PubMed]
  104. Felka, T.; Rothdiener, M.; Bast, S.; Uynuk-Ool, T.; Zouhair, S.; Ochs, B.G.; de Zwart, P.; Stoeckle, U.; Aicher, W.K.; Hart, M.L.; et al. Loss of spatial organization and destruction of the pericellular matrix in early osteoarthritis in vivo and in a novel in vitro methodology. Osteoarthr. Cartil. 2016, 24, 1200–1209. [Google Scholar] [CrossRef] [Green Version]
  105. Danalache, M.; Erler, A.L.; Wolfgart, J.M.; Schwitalle, M.; Hofmann, U.K. Biochemical changes of the pericellular matrix and spatial chondrocyte organization-Two highly interconnected hallmarks of osteoarthritis. J. Orthop. Res. 2020, 38, 2170–2180. [Google Scholar] [CrossRef]
  106. Guilak, F.; Nims, R.J.; Dicks, A.; Wu, C.L.; Meulenbelt, I. Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol. 2018, 71–72, 40–50. [Google Scholar] [CrossRef]
  107. Wilusz, R.; DeFrate, L.E.; Guilak, F. Immunofluorescence-guided atomic force microscopy to measure the micromechanical properties of the pericellular matrix of porcine articular cartilage. J. R. Soc. Interface 2012, 9, 2997–3007. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  108. Wilusz, R.; Zauscher, S.; Guilak, F. Micromechanical mapping of early osteoarthritic changes in the pericellular matrix of human articular cartilage. Osteoarthr. Cartil. 2013, 21, 1895–1903. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  109. Fermor, H.; McLure, S.W.; Taylor, S.D.; Russell, S.L.; Williams, S.; Fisher, J.; Ingham, E. The elastin network: Its relationship with collagen and cells in articular cartilage as visualized by multiphoton microscopy. Biomed. Mater. Eng. 2015, 25, 381–395. [Google Scholar] [PubMed]
  110. Zhao, Z.; Li, Y.; Wang, M.; Zhao, S.; Zhao, Z.; Fang, J. Mechanotransduction pathways in the regulation of cartilage chondrocyte homoeostasis. J. Cell Mol. Med. 2020, 24, 5408–5419. [Google Scholar] [CrossRef] [Green Version]
  111. Khoshgoftar, M.; Torzilli, P.A.; Maher, S.A. Influence of the pericellular and extracellular matrix structural properties on chondrocyte mechanics. J. Orthop. Res. 2018, 36, 721–729. [Google Scholar] [CrossRef]
  112. Chen, C.; Tambe, D.T.; Deng, L.; Yang, L. Biomechanical properties and mechanobiology of the articular chondrocyte. Am. J. Physiol. Cell Physiol. 2013, 305, C1202–C1208. [Google Scholar] [CrossRef] [Green Version]
  113. Whitelock, J.M.; Melrose, J.; Iozzo, R.V. Diverse cell signaling events modulated by perlecan. Biochemistry 2008, 47, 11174–11183. [Google Scholar] [CrossRef] [Green Version]
  114. Melrose, J.; Smith, S.; Cake, M.; Read, R.; Whitelock, J. Comparative spatial and temporal immunolocalisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: An ageing study. Histochem. Cell Biol. 2005, 124, 225–235. [Google Scholar] [CrossRef]
  115. Green, E.; Mansfield, J.C.; Bell, J.S.; Winlove, C.P. The structure and micromechanics of elastic tissue. Interface Focus 2014, 4, 20130058. [Google Scholar] [CrossRef] [Green Version]
  116. Yu, J.; Tirlapur, U.; Fairbank, J.; Handford, P.; Roberts, S.; Winlove, C.P.; Cui, Z.; Urban, J. Microfibrils, elastin fibres and collagen fibres in the human intervertebral disc and bovine tail disc. J. Anat. 2007, 210, 460–471. [Google Scholar] [CrossRef]
  117. Li, B.; Urban, J.P.; Yu, J. The distribution of fibrillin-2 and LTBP-2, and their co-localisation with fibrillin-1 in adult bovine tail disc. J. Anat. 2012, 220, 164–172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  118. He, B.; Wu, J.P.; Xu, J.; Day, R.E.; Kirk, T.B. Microstructural and compositional features of the fibrous and hyaline cartilage on the medial tibial plateau imply a unique role for the hopping locomotion of kangaroo. PLoS ONE 2013, 8, e74303. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  119. He, B.; Wu, J.P.; Chim, S.M.; Xu, J.; Kirk, T.B. Microstructural analysis of collagen and elastin fibres in the kangaroo articular cartilage reveals a structural divergence depending on its local mechanical environment. Osteoarthr. Cartil. 2013, 21, 237–245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  120. Ali, T.; Thibbotuwawa, N.; Gu, Y.; Momot, K.I. MRI magic-angle effect in femorotibial cartilages of the red kangaroo. Magn. Reson. Imaging 2017, 43, 66–73. [Google Scholar] [CrossRef] [PubMed]
  121. Yu, J.; Urban, J.P. The elastic network of articular cartilage: An immunohistochemical study of elastin fibres and microfibrils. J. Anat. 2010, 216, 533–541. [Google Scholar] [CrossRef]
  122. Mithieux, S.; Weiss, A.S. Elastin. Adv. Protein Chem. 2005, 70, 437–461. [Google Scholar]
  123. Kannus, P. Structure of the tendon connective tissue. Scand. J. Med. Sci. Sports 2000, 10, 312–320. [Google Scholar] [CrossRef] [PubMed]
  124. Ritty, T.; Ditsios, K.; Starcher, B.C. Distribution of the elastic fiber and associated proteins in flexor tendon reflects function. Anat. Rec. 2002, 268, 430–440. [Google Scholar] [CrossRef] [PubMed]
  125. He, B.; Wu, J.P.; Kirk, T.B.; Carrino, J.A.; Xiang, C.; Xu, J. High-resolution measurements of the multilayer ultra-structure of articular cartilage and their translational potential. Arthritis Res. Ther. 2014, 16, 205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  126. Hayes, A.; Melrose, J. Glycosaminoglycan and Proteoglycan Biotherapeutics in Articular Cartilage Protection and Repair Strategies: Novel Approaches to Visco-supplementation in Orthobiologics. Adv. Ther. 2019, 2, 1900034. [Google Scholar] [CrossRef]
Ijms 22 02716 g001 550
Figure 1. Schematic of the perlecan and its five modular domains (a). and their interactive ligands (b).
Figure 1. Schematic of the perlecan and its five modular domains (a). and their interactive ligands (b).
Ijms 22 02716 g001
Ijms 22 02716 g002 550
Figure 2. Perlecan and FGF-2 are prominent components of the PCM of chondrocytes. (a–d) Immunolocalisation of perlecan in an adult ovine stifle joint. Left panel: Macroscopic views showing femoral condyle (a) and tibial plateau (b). Right panel: High power views demonstrating perlecan’s pericellular distribution in femoral condyle (c) and tibial plateau (d). Figure (a–d) based on data originally published in [50].
Figure 2. Perlecan and FGF-2 are prominent components of the PCM of chondrocytes. (a–d) Immunolocalisation of perlecan in an adult ovine stifle joint. Left panel: Macroscopic views showing femoral condyle (a) and tibial plateau (b). Right panel: High power views demonstrating perlecan’s pericellular distribution in femoral condyle (c) and tibial plateau (d). Figure (a–d) based on data originally published in [50].
Ijms 22 02716 g002
Ijms 22 02716 g003 550
Figure 3. Perlecan promotes elastin formation by IVD cells. Three-dimensional surface rendered models of perlecan, elastin and type VI collagen immunolocalization in intervertebral disc tissues, based on confocal data originally published in [54,38]. Upper panel: Annulus fibrosus cells shown in (a,b), nucleus pulposus cells in (c,d). Secretion of co-acervated tropoelastin (green) is visible at the poles of the elongate, spindle shaped annulus fibrosus cells, perlecan label (red) extends outwards from the pericellular matrix compartment at the cell poles (a,b). In contrast, elastin is only sparsely distributed around NP cell clusters (c,d). Detail of the elastin labeling (boxed area in (c) is shown in (d) Arrows denote perlecan foci associated with elastin label in (d). Lower panel: The lower image (e) shows the overlapping distributions of collagen type VI (green) and pericellular perlecan label (red) within an annulus fibrosus chondron. Cell nuclei depicted in blue.
Figure 3. Perlecan promotes elastin formation by IVD cells. Three-dimensional surface rendered models of perlecan, elastin and type VI collagen immunolocalization in intervertebral disc tissues, based on confocal data originally published in [54,38]. Upper panel: Annulus fibrosus cells shown in (a,b), nucleus pulposus cells in (c,d). Secretion of co-acervated tropoelastin (green) is visible at the poles of the elongate, spindle shaped annulus fibrosus cells, perlecan label (red) extends outwards from the pericellular matrix compartment at the cell poles (a,b). In contrast, elastin is only sparsely distributed around NP cell clusters (c,d). Detail of the elastin labeling (boxed area in (c) is shown in (d) Arrows denote perlecan foci associated with elastin label in (d). Lower panel: The lower image (e) shows the overlapping distributions of collagen type VI (green) and pericellular perlecan label (red) within an annulus fibrosus chondron. Cell nuclei depicted in blue.
Ijms 22 02716 g003
Ijms 22 02716 g004 550
Figure 4. Schematic depiction of the elastic microbril, containing perlecan and fibrillin as functional omponents. (a) Schematic depiction of an elastic microfibril and its components. Electron micrographs of tannic acid-glutaraldehyde-fixed samples demonstrating the central amorphous elastin (E) within a microfibril in (b) longitudinal (magnification ×18,000) and (c) cross-section (magnification ×85,000); (d) Rotary shadowing images showing the characteristic interrupted globular domains in type VI collagen. Segment b, c reproduced from [55]. Segment d [56] under Open Access. Arrows in (b). depict microfibrillar material, E amorphous elastin. Arrowheads in (c). depict microfibrils in cross section, whilst arrows indicate collagen fibres in cross section.
Figure 4. Schematic depiction of the elastic microbril, containing perlecan and fibrillin as functional omponents. (a) Schematic depiction of an elastic microfibril and its components. Electron micrographs of tannic acid-glutaraldehyde-fixed samples demonstrating the central amorphous elastin (E) within a microfibril in (b) longitudinal (magnification ×18,000) and (c) cross-section (magnification ×85,000); (d) Rotary shadowing images showing the characteristic interrupted globular domains in type VI collagen. Segment b, c reproduced from [55]. Segment d [56] under Open Access. Arrows in (b). depict microfibrillar material, E amorphous elastin. Arrowheads in (c). depict microfibrils in cross section, whilst arrows indicate collagen fibres in cross section.
Ijms 22 02716 g004
Ijms 22 02716 g005 550
Figure 5. Perlecan interacts with cell surface integrins and type XI collagen in the PCM. (a) Diagrammatic schematic representation of the interaction of perlecan with cell surface integrins and the HSbinding sites of type XI collagen at the ovine disc cell surface. (b,c) Immunoperoxidase localisation of type XI collagen (b) and perlecan HS (c) in monolayer cultures of annulus fibrosus cells. (d) Schematic of the HS binding sites on the exposed Npp α1 domain of a type XI collagen heterofibril (e) Immunofluorescence localisation of type XI collagen in cultured chondrosarcoma cells showing pericellular HS-PGs. Segments a-c reproduced from [63]. Segments d and e reproduced from [64]. All plates in (e) are provided at the same magnification, 20 µm scale bar applicable to all segments.
Figure 5. Perlecan interacts with cell surface integrins and type XI collagen in the PCM. (a) Diagrammatic schematic representation of the interaction of perlecan with cell surface integrins and the HSbinding sites of type XI collagen at the ovine disc cell surface. (b,c) Immunoperoxidase localisation of type XI collagen (b) and perlecan HS (c) in monolayer cultures of annulus fibrosus cells. (d) Schematic of the HS binding sites on the exposed Npp α1 domain of a type XI collagen heterofibril (e) Immunofluorescence localisation of type XI collagen in cultured chondrosarcoma cells showing pericellular HS-PGs. Segments a-c reproduced from [63]. Segments d and e reproduced from [64]. All plates in (e) are provided at the same magnification, 20 µm scale bar applicable to all segments.
Ijms 22 02716 g005
Ijms 22 02716 g006 550
Figure 6. Colocalisation of perlecan and elastin in blood vessels. Confocal immunofluorescence localisations of perlecan and elastin in the basement membrane of a paraspinal blood vessel from a 14-week-old human foetal spinal specimen (a–d). Perlecan (red) and elastin (green) are colocalised (yellow) at the lumenal surface of the endothelial cell basement membrane of the blood vessel. The boxed area in (d) is shown at higher magnification in (e–h). (i,j) Elastin immunolocalisations are also shown in an additional paraspinal capillary (i) and in a venule (j). Cell nuclei depicted with DAPI staining (blue). Image reproduced from [54].
Figure 6. Colocalisation of perlecan and elastin in blood vessels. Confocal immunofluorescence localisations of perlecan and elastin in the basement membrane of a paraspinal blood vessel from a 14-week-old human foetal spinal specimen (a–d). Perlecan (red) and elastin (green) are colocalised (yellow) at the lumenal surface of the endothelial cell basement membrane of the blood vessel. The boxed area in (d) is shown at higher magnification in (e–h). (i,j) Elastin immunolocalisations are also shown in an additional paraspinal capillary (i) and in a venule (j). Cell nuclei depicted with DAPI staining (blue). Image reproduced from [54].
Ijms 22 02716 g006
Ijms 22 02716 g007 550
Figure 7. Perlecan interacts with fibrillin-1 and versican in the annulus fibrosus. (a–c) Confocal immunofluorescence localisations of perlecan (red in a,c), fibrillin-1 (green) and versican (red in b) in the annulus fibrosus of the human foetal intervertebral disc (a,b) and posterior longitudinal ligament (PLL; cc). (d) Immunoperoxidase image shows that elastin fibres act as anchorage points for the attachment of annular lamellae to cartilaginous endplates (e,f) Elastin immunolocalisation within the anterior longitudinal ligament (ALL) shown by confocal (e) and brightfield microscopy (f) Cell nuclei depicted in blue. Figures modified from [51,52,53,54] with permission.
Figure 7. Perlecan interacts with fibrillin-1 and versican in the annulus fibrosus. (a–c) Confocal immunofluorescence localisations of perlecan (red in a,c), fibrillin-1 (green) and versican (red in b) in the annulus fibrosus of the human foetal intervertebral disc (a,b) and posterior longitudinal ligament (PLL; cc). (d) Immunoperoxidase image shows that elastin fibres act as anchorage points for the attachment of annular lamellae to cartilaginous endplates (e,f) Elastin immunolocalisation within the anterior longitudinal ligament (ALL) shown by confocal (e) and brightfield microscopy (f) Cell nuclei depicted in blue. Figures modified from [51,52,53,54] with permission.
Ijms 22 02716 g007
Ijms 22 02716 g008 550
Figure 8. Perlecan and elastin are components of a basal lamina in the knee joint endothelium. (a) Haematoxylin & eosin stained tissue section of an 18 month old ovine knee synovium specimen. Confocal localisation of perlecan (b, red), elastin (c, green), DAPI-stained cell nuclei (d) and merged image showing colocalisation of perlecan and elastin (e, yellow) within an elastic lamina and surrounding a synovial blood vessel. The arrows indicate the surface of the synovium.The asterisk indicates a blood vessel in the synovium. Figure reproduced from [54] with permission.
Figure 8. Perlecan and elastin are components of a basal lamina in the knee joint endothelium. (a) Haematoxylin & eosin stained tissue section of an 18 month old ovine knee synovium specimen. Confocal localisation of perlecan (b, red), elastin (c, green), DAPI-stained cell nuclei (d) and merged image showing colocalisation of perlecan and elastin (e, yellow) within an elastic lamina and surrounding a synovial blood vessel. The arrows indicate the surface of the synovium.The asterisk indicates a blood vessel in the synovium. Figure reproduced from [54] with permission.
Ijms 22 02716 g008
Ijms 22 02716 g009 550
Figure 9. Elastin fibres are components of knee joint articular cartilage. (a) Scanning electron micrograph showing the fibrous structure of a chondron surrounding an articular cartilagechondrocyte (b) Surface rendered model of a chondron showing the 3D organisation of type VI collagen (green) and perlecan (red) based on confocal data published in [42] (c,d) Immunofluorescence localisation of elastin (green) within knee joint articular cartilage. Elastin occurs as discrete matrix fibres and as pericellular material focused around chondrocytes. (e) Diagrammatic representation of the structural components surrounding articular chondrocytes. Elastin fibres are shown in green. Images a, c, d reproduced from [125] through Open Access. Image e modified [126] under Open Access.
Figure 9. Elastin fibres are components of knee joint articular cartilage. (a) Scanning electron micrograph showing the fibrous structure of a chondron surrounding an articular cartilagechondrocyte (b) Surface rendered model of a chondron showing the 3D organisation of type VI collagen (green) and perlecan (red) based on confocal data published in [42] (c,d) Immunofluorescence localisation of elastin (green) within knee joint articular cartilage. Elastin occurs as discrete matrix fibres and as pericellular material focused around chondrocytes. (e) Diagrammatic representation of the structural components surrounding articular chondrocytes. Elastin fibres are shown in green. Images a, c, d reproduced from [125] through Open Access. Image e modified [126] under Open Access.
Ijms 22 02716 g009
Ijms 22 02716 g010 550
Figure 10. Correlative co-localization of perlecan and type VI collagen with the biomechanical properties of cartilage. (a–c) Dual immunofluorescence labeling of type VI collagen (a, red), and perlecan (b, green) within the pericellular matrix compartment of articular cartilage. The adjacent overlay image (c) shows their overlapping distributions. Scale bar = 5 μm. (d) Contour map of the calculated elastic moduli for the pericellular matrix region shown in (a–c), as determined by AFM scanning. (e) Elastic moduli of cartilage extracellular matrix (ECM) and pericellular matrix (PCM) as defined by the presence of type VI collagen or perlecan. There is no difference between biochemical definitions of the PCM (p = 0.70). ECM elastic moduli were significantly greater than PCM moduli (a: p < 0.005 as compared to either PCM definition). (f) Regions that were dual-labeled for type VI collagen and perlecan exhibited lower elastic moduli than regions positive for type VI collagen or perlecan alone (b: p < 0.05 as compared to type VI collagen and perlecan alone regions). Data presented as Mean + SEM. Figure reproduced from [43] with permission.
Figure 10. Correlative co-localization of perlecan and type VI collagen with the biomechanical properties of cartilage. (a–c) Dual immunofluorescence labeling of type VI collagen (a, red), and perlecan (b, green) within the pericellular matrix compartment of articular cartilage. The adjacent overlay image (c) shows their overlapping distributions. Scale bar = 5 μm. (d) Contour map of the calculated elastic moduli for the pericellular matrix region shown in (a–c), as determined by AFM scanning. (e) Elastic moduli of cartilage extracellular matrix (ECM) and pericellular matrix (PCM) as defined by the presence of type VI collagen or perlecan. There is no difference between biochemical definitions of the PCM (p = 0.70). ECM elastic moduli were significantly greater than PCM moduli (a: p < 0.005 as compared to either PCM definition). (f) Regions that were dual-labeled for type VI collagen and perlecan exhibited lower elastic moduli than regions positive for type VI collagen or perlecan alone (b: p < 0.05 as compared to type VI collagen and perlecan alone regions). Data presented as Mean + SEM. Figure reproduced from [43] with permission.
Ijms 22 02716 g010
Ijms 22 02716 g011 550
Figure 11. Integration of AFM force maps (a–c) and fluorescence immunolabeling of perlecan in the meniscus (d–f). To determine the micromechanical properties of the pericellular matrix (PCM) within the meniscus, meniscal tissue samples were cryosectioned and immunofluorescently labeled for perlecan, which has been shown previously to be localized to this matrix compartment within the meniscus [114]. PCM and ECM properties were evaluated as described previously [43] with PCM sites identified by positive pericellular labeling for perlecan and ECM sites identified by a lack of perlecan staining. Force maps of 20 × 20 µm pericellular regions within each meniscus region (top row) were integrated with fluorescent perlecan staining (middle row) to define PCM boundaries. The resulting PCM force maps were analysed to yield an average elastic modulus (g–i). Figure reproduced from [68] with permission.
Figure 11. Integration of AFM force maps (a–c) and fluorescence immunolabeling of perlecan in the meniscus (d–f). To determine the micromechanical properties of the pericellular matrix (PCM) within the meniscus, meniscal tissue samples were cryosectioned and immunofluorescently labeled for perlecan, which has been shown previously to be localized to this matrix compartment within the meniscus [114]. PCM and ECM properties were evaluated as described previously [43] with PCM sites identified by positive pericellular labeling for perlecan and ECM sites identified by a lack of perlecan staining. Force maps of 20 × 20 µm pericellular regions within each meniscus region (top row) were integrated with fluorescent perlecan staining (middle row) to define PCM boundaries. The resulting PCM force maps were analysed to yield an average elastic modulus (g–i). Figure reproduced from [68] with permission.
Ijms 22 02716 g011
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Guilak, F.; Hayes, A.J.; Melrose, J. Perlecan in Pericellular Mechanosensory Cell-Matrix Communication, Extracellular Matrix Stabilisation and Mechanoregulation of Load-Bearing Connective Tissues. Int. J. Mol. Sci. 2021, 22, 2716. https://doi.org/10.3390/ijms22052716

AMA Style

Guilak F, Hayes AJ, Melrose J. Perlecan in Pericellular Mechanosensory Cell-Matrix Communication, Extracellular Matrix Stabilisation and Mechanoregulation of Load-Bearing Connective Tissues. International Journal of Molecular Sciences. 2021; 22(5):2716. https://doi.org/10.3390/ijms22052716

Chicago/Turabian Style

Guilak, Farshid, Anthony J. Hayes, and James Melrose. 2021. "Perlecan in Pericellular Mechanosensory Cell-Matrix Communication, Extracellular Matrix Stabilisation and Mechanoregulation of Load-Bearing Connective Tissues" International Journal of Molecular Sciences 22, no. 5: 2716. https://doi.org/10.3390/ijms22052716

APA Style

Guilak, F., Hayes, A. J., & Melrose, J. (2021). Perlecan in Pericellular Mechanosensory Cell-Matrix Communication, Extracellular Matrix Stabilisation and Mechanoregulation of Load-Bearing Connective Tissues. International Journal of Molecular Sciences, 22(5), 2716. https://doi.org/10.3390/ijms22052716

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop